Skip to main content

Advertisement

SpringerLink
Log in

Pilot study of treatment of patients with deep infiltrative endometriosis with methotrexate carried in lipid nanoparticles

  • Gynecologic Endocrinology and Reproductive Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

Previously, lipid nanoparticles (LDE) injected in women with endometriosis were shown to concentrate in the lesions. Here, the safety and feasibility of LDE carrying methotrexate (MTX) to treat deep infiltrating endometriosis was tested.

Design

Prospective pilot study.

Setting

Perola Byington Hospital Reference for Women’s Health.

Subjects

Eleven volunteers (aged 30–47 years, BMI 26.15 ± 6.50 kg/m2) with endometriosis with visual analog scale pelvic pain scores (VAS) > 7 and rectosigmoid lesions were enrolled in the study.

Intervention

Three patients were treated with LDE–MTX at single intravenous 25 mg/m2 dose of MTX and eight patients with two 25 mg/m2 doses with 1-week interval.

Main outcome measures

Clinical complaints, blood count, and biochemistry were analyzed before treatment and on days 90, 120, and 180 after LDE–MTX administration. Endometriotic lesions were evaluated by pelvic and transvaginal ultrasound (TVUS) before treatment and on days 30 and 180 after LDE–MTX administration.

Results

No clinical complaints related with LDE–MTX treatment were reported by the patients, and no hematologic, renal, or hepatic toxicities were observed in the laboratorial exams. FSH, LH, TSH, free T4, anti-Müllerian hormone, and prolactin levels were also within normal ranges during the observation period. Scores for deep dyspareunia (p < 0.001), chronic pelvic pain (p = 0.008), and dyschezia (p = 0.025) were improved over the 180-day observation period. There was a non-significant trend for reduction of VAS scores for dysmenorrhea. Bowel lesions by TVUS were unchanged. No clear differences between the two dose levels in therapeutic responses were observed.

Conclusion

Results support the safety and feasibility of using LDE–MTX in women with deep infiltrating endometriosis as a novel and promising therapy for the disease. More prolonged treatment schemes should be tested in future placebo-controlled studies aiming to establish the usefulness of this novel nanomedicine approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Howard FM (2009) Endometriosis and mechanisms of pelvic pain. J Minim Invasive Gynecol 16:540–550

    Article  PubMed  Google Scholar 

  2. Machairiotis N, Vasilakaki S, Thomakos N (2021) Inflammatory mediators and pain in endometriosis: a systematic review. Biomedicines 9:54

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Podgaec S, Abrao MS, Dias JA Jr, Rizzo LV, de Oliveira RM, Baracat EC (2007) Endometriosis: an inflammatory disease with a Th2 immune response component. Hum Reprod 22:1373–1379

    Article  CAS  PubMed  Google Scholar 

  4. Nothnick W, Alali Z (2016) Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment. F1000Res 5:Faculty Rev-186

    Article  PubMed  Google Scholar 

  5. Gueuvoghlanian-Silva BY, Bellelis P, Barbeiro DF, Hernandes C, Podgaec S (2018) Treg and NK cells related cytokines are associated with deep rectosigmoid endometriosis and clinical symptoms related to the disease. J Reprod Immunol 126:32–38

    Article  CAS  PubMed  Google Scholar 

  6. Riccio LDGC, Santulli P, Marcellin L, Abrão MS, Batteux F, Chapron C (2018) Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 50:39–49

    Article  PubMed  Google Scholar 

  7. Bellelis P, Frediani Barbeiro D, Gueuvoghlanian-Silva BY, Kalil J, Abrão MS, Podgaec S (2019) Interleukin-15 and Interleukin-7 are the major cytokines to maintain endometriosis. Gynecol Obstet Invest 84:435–444

    Article  CAS  PubMed  Google Scholar 

  8. Malvezzi H, Hernandes C, Piccinato CA, Podgaec S (2019) Interleukin in endometriosis-associated infertility-pelvic pain: systematic review and meta-analysis. Reproduction 158:1–12

    Article  CAS  PubMed  Google Scholar 

  9. Andres MP, Mendes RFP, Hernandes C, Araújo SEA, Podgaec S (2019) Hormone treatment as first line therapy is safe and relieves pelvic pain in women with bowel endometriosis. Einstein (Sao Paulo) 17:eA04583

    Article  Google Scholar 

  10. Zondervan KT, Becker CM, Missmer SA (2020) Endometriosis. N Engl J Med 382:1244–1256

    Article  CAS  PubMed  Google Scholar 

  11. Samy A, Taher A, Sileem SA, Abdelhakim AM, Fathi M, Haggag H et al (2021) Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials. J Gynecol Obstet Hum Reprod 50:101798

    Article  PubMed  Google Scholar 

  12. Duffy JM, Arambage K, Correa FJ, Olive D, Farquhar C, Garry R et al (2014) Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev 4:CD011031

    Google Scholar 

  13. de Paula AM, Borrelli GM, Kho RM, Abrão MS (2017) The current management of deep endometriosis: a systematic review. Minerva Ginecol 69:587–596

    Google Scholar 

  14. Bafort C, Beebeejaun Y, Tomassetti C, Bosteels J, Duffy JM (2020) Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev 10:CD011031

    PubMed  Google Scholar 

  15. Abo C, Moatassim S, Marty N, Saint Ghislain M, Huet E, Bridoux V et al (2018) Postoperative complications after bowel endometriosis surgery by shaving, disc excision, or segmental resection: a three-arm comparative analysis of 364 consecutive cases. Fertil Steril 109:172-178.e1

    Article  PubMed  Google Scholar 

  16. Imboden S, Bollinger Y, Härmä K, Knabben L, Fluri M, Nirgianakis K, et al (2021) Predictive factors for voiding dysfunction after surgery for deep infiltrating endometriosis. J Minim Invasive Gynecol, p S1553-4650(21)00037-6

  17. Tschann P, Vitlarov N, Hufschmidt M, Lechner D, Girotti PNC, Offner F et al (2021) Colorectal resection in endometriosis patients: correlation between histopathological findings and postoperative outcome. Eur J Med Res 26:12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Roman H, Bridoux V, Merlot B, Resch B, Chati R, Coget J et al (2020) Risk of bowel fistula following surgical management of deep endometriosis of the rectosigmoid: a series of 1102 cases. Hum Reprod 35:1601–1611

    Article  PubMed  PubMed Central  Google Scholar 

  19. Turco LC, Tortorella L, Tuscano A, Palumbo MA, Fagotti A, Uccella S et al (2020) Surgery-related complications and long-term functional morbidity after segmental colo-rectal resection for deep infiltrating endometriosis (ENDO- RESECT morb). Arch Gynecol Obstet 302:983–993

    Article  PubMed  Google Scholar 

  20. Thomas EJ, Campbell IG (2000) Evidence that endometriosis behaves in a malignant manner. Gynecol Obstet Invest 50(Suppl 1):2–10

    Article  PubMed  Google Scholar 

  21. Abrao MS, Podgaec S, Dias JA Jr, Averbach M, Garry R, Ferraz Silva LF et al (2006) Deeply infiltrating endometriosis affecting the rectum and lymph nodes. Fertil Steril 86:543–547

    Article  PubMed  Google Scholar 

  22. Kvaskoff M, Mahamat-Saleh Y, Farland LV, Shigesi N, Terry KL, Harris HR et al (2021) Endometriosis and cancer: a systematic review and meta-analysis. Hum Reprod Update 27:393–420

    Article  CAS  PubMed  Google Scholar 

  23. Ho YK, Smith RG, Brown MS, Goldstein JL (1978) Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. Blood 52:1099–1114

    Article  CAS  PubMed  Google Scholar 

  24. Gabitova L, Gorin A, Astsaturov I (2014) Molecular pathways: sterols and receptor signaling in cancer. Clin Cancer Res 20:28–34

    Article  CAS  PubMed  Google Scholar 

  25. Maranhão RC, Graziani SR, Yamaguchi N, Melo RF, Latrilha MC, Rodrigues DG et al (2002) Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients. Cancer Chemother Pharmacol 49:487–498

    Article  PubMed  Google Scholar 

  26. Valduga CJ, Fernandes DC, Lo Prete AC, Azevedo CH, Rodrigues DG, Maranhão RC (2003) Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposide. J Pharm Pharmacol 55:1615–1622

    Article  CAS  PubMed  Google Scholar 

  27. Rodrigues DG, Maria DA, Fernandes DC, Valduga CJ, Couto RD, Ibañez OC et al (2005) Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies. Cancer Chemother Pharmacol 55:565–576

    Article  CAS  PubMed  Google Scholar 

  28. Mello SB, Tavares ER, Bulgarelli A, Bonfá E, Maranhão RC (2013) Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis. Int J Nanomedicine 8:443–449

    PubMed  PubMed Central  Google Scholar 

  29. Gibran L, Maranhão RC, Tavares ER, Carvalho PO, Abrão MS, Podgaec S (2017) mRNA levels of low-density lipoprotein receptors are overexpressed in the foci of deep bowel endometriosis. Hum Reprod 32:332–339

    Article  CAS  PubMed  Google Scholar 

  30. Bedin A, Maranhão RC, Tavares ER, Carvalho PO, Baracat EC, Podgaec S (2019) Nanotechnology for the treatment of deep endometriosis: uptake of lipid core nanoparticles by LDL receptors in endometriotic foci. Clinics (Sao Paulo) 74:e989

    Article  PubMed  Google Scholar 

  31. Huennekens FM (1994) The methotrexate story: a paradigm for development of cancer chemotherapeutic agents. Adv Enzyme Regul 34:397–419

    Article  CAS  PubMed  Google Scholar 

  32. Abolmaali SS, Tamaddon AM, Dinarvand R (2013) A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis. Cancer Chemother Pharmacol 71:1115–1130

    Article  CAS  PubMed  Google Scholar 

  33. Rana P, Kazmi I, Singh R, Afzal M, Al-Abbasi FA, Aseeri A et al (2013) Ectopic pregnancy: a review. Arch Gynecol Obstet 288:747–757

    Article  PubMed  Google Scholar 

  34. Mello SB, Tavares ER, Guido MC, Bonfá E, Maranhão RC (2016) Anti-inflammatory effects of intravenous methotrexate associated with lipid nanoemulsions on antigen-induced arthritis. Clinics (Sao Paulo) 71:54–58

    Article  PubMed  Google Scholar 

  35. Fiorelli AI, Lourenço-Filho DD, Tavares ER, Carvalho PO, Marques AF, Gutierrez PS et al (2017) Methotrexate associated to lipid core nanoparticles improves cardiac allograft vasculopathy and the inflammatory profile in a rabbit heart graft model. Braz J Med Biol Res 50:e6225

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Bulgarelli A, Martins Dias AA, Caramelli B, Maranhão RC (2012) Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits. J Cardiovasc Pharmacol 59:308–314

    Article  CAS  PubMed  Google Scholar 

  37. Maranhão RC, Guido MC, de Lima AD, Tavares ER, Marques AF, Tavares de Melo MD et al (2017) Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats. Int J Nanomedicine 12:3767–3784

    Article  PubMed  PubMed Central  Google Scholar 

  38. Guido MC, Lopes NM, Albuquerque CI, Tavares ER, Jensen L, Carvalho PO et al (2022) Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome. Front Cardiovasc Med 9:893774

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Maxwell C (1978) Sensitivity and accuracy of the visual analogue scale: a psycho- physical classroom experiment. Br J Clin Pharmacol 6:15–24

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Chapron C, Fauconnier A, Vieira M, Barakat H, Dousset B, Pansini V et al (2003) Anatomical distribution of deeply infiltrating endometriosis: surgical implications and proposition for a classification. Hum Reprod 18:157–161

    Article  PubMed  Google Scholar 

  41. Goncalves MO, Podgaec S, Dias JA Jr, Gonzalez M, Abrao MS (2010) Transvaginal ultrasonography with bowel preparation is able to predict the number of lesions and rectosigmoid layers affected in cases of deep endometriosis, defining surgical strategy. Hum Reprod 25:665–671

    Article  PubMed  Google Scholar 

  42. Goncalves MO, Siufi Neto J, Andres MP, Siufi D, de Mattos LA, Abrao MS (2021) Systematic evaluation of endometriosis by transvaginal ultrasound can accurately replace diagnostic laparoscopy, mainly for deep and ovarian endometriosis. Hum Reprod, p deab085

  43. Moura JA, Valduga CJ, Tavares ER, Kretzer IF, Maria DA, Maranhão RC (2011) Novel formulation of a methotrexate derivative with a lipid nanoemulsion. Int J Nanomedicine 6:2285–2295

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Rosowsky A, Forsch RA, Yu CS, Lazarus H, Beardsley GP (1984) Methotrexate analogues. 21. Divergent influence of alkyl chain length on the dihydrofolate reductase affinity and cytotoxicity of methotrexate monoesters. J Med Chem 27:605–609

    Article  CAS  PubMed  Google Scholar 

  45. Abrao MS, Andres MP, da Cunha VM, Borrelli GM, Neto JS (2021) Clinical and sonographic progression of bowel endometriosis: 3-year follow-up. Reprod Sci 28:675–682

    Article  PubMed  Google Scholar 

  46. Shirazi M, Pooransari P, Hajiha N, Shaker Z, Ghazi M, Davari Tanha F et al (2020) Effect of single-dose methotrexate treatment on ovarian reserve in women with ectopic pregnancy undergoing infertility treatment: a single-center experience. Int J Fertil Steril. 14(1):23–26

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Taylor PC, Balsa Criado A, Mongey A-B, Avouac J, Marotte H, Mueller RB (2019) How to get the most from methotrexate (MTX) Treatment for your rheumatoid arthritis patient?—MTX in the treat-to-target strategy. J Clin Med 8(4):515

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Rohr SS, Maranhão RC, Tavoni TM, Morikawa AT, Areco K, Deus DF et al (2020) Novel approach for bone marrow transplantation conditioning in acute myelogenous leukemia not responding to the induction therapy using etoposide carried in lipid core nanoparticles: a pilot clinical study. Biol Blood Marrow Transplant 26(11):2027–2033

    Article  CAS  PubMed  Google Scholar 

  49. Shiozaki AA, Senra T, Morikawa AT, Deus DF, Paladino-Filho AT, Pinto IM et al (2016) Treatment of patients with aortic atherosclerotic disease with paclitaxel- associated lipid nanoparticles. Clinics (Sao Paulo) 71:435–439

    Article  PubMed  Google Scholar 

  50. Fauconnier A, Chapron C, Dubuisson JB, Vieira M, Dousset B, Bréart G (2002) Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis. Fertil Steril 78:719–726

    Article  PubMed  Google Scholar 

  51. Fauconnier A, Chapron C (2005) Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update 11:595–606

    Article  CAS  PubMed  Google Scholar 

  52. Abrao MS, Gonçalves MO, Dias JA Jr, Podgaec S, Chamie LP, Blasbalg R (2007) Comparison between clinical examination, transvaginal sonography and magnetic resonance imaging for the diagnosis of deep endometriosis. Hum Reprod 22:3092–3097

    Article  PubMed  Google Scholar 

  53. Hudelist G, English J, Thomas AE, Tinelli A, Singer CF, Keckstein J (2011) Diagnostic accuracy of transvaginal ultrasound for non-invasive diagnosis of bowel endometriosis: systematic review and meta-analysis. Ultrasound Obstet Gynecol 37:257–263

    Article  CAS  PubMed  Google Scholar 

  54. Indrielle-Kelly T, Frühauf F, Fanta M, Burgetova A, Lavu D, Dundr P, et al. Diagnostic Accuracy of Ultrasound and MRI in the Mapping of Deep Pelvic Endometriosis Using the International Deep Endometriosis Analysis (IDEA) Consensus (2020) Biomed Res Int, p 3583989

  55. Leonardo-Pinto JP, Benetti-Pinto CL, Cursino K, Yela DA (2017) Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission. Eur J Obstet Gynecol Reprod Biol 211:108–111

    Article  PubMed  Google Scholar 

  56. Netter A, d’Avout-Fourdinier P, Agostini A, Chanavaz-Lacheray I, Lampika M, Farella M et al (2019) Progression of deep infiltrating rectosigmoid endometriotic nodules. Hum Reprod 34:2144–2152

    PubMed  Google Scholar 

  57. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247

    Article  CAS  PubMed  Google Scholar 

  58. Egekvist AG, Marinovskij E, Forman A, Kesmodel US, Graumann O, Seyer- HM (2019) Conservative treatment of rectosigmoid endometriosis: a prospective study. Acta Obstet Gynecol Scand 98:11

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank Helymar da Costa Machado, statistician from Hospital da Mulher (CAISM), University of Campinas, for assistance with the statistical analysis. We would also like to thank Kelly Mancini, a supervising nurse of the chemotherapy sector at the Perola Byington Hospital, for providing all the logistic organizations to receive our patients.

Funding

This study was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, grant 2014/03742-0), Brazil.

Author information

Authors and Affiliations

  1. Gynecological Endoscopy Center of the Perola Byington Hospital Reference for Women’s Health, São Paulo, Brazil

    Roberta Avila-Tavares & Luciano Gibran

  2. Department of Obstetrics and Gynecology, School of Medical Sciences, University of Campinas, Campinas, Brazil

    Roberta Avila-Tavares & Luiz Gustavo Oliveira Brito

  3. Lipid Metabolism Laboratory, Heart Institute, University of Sao Paulo, São Paulo, Brazil

    Thauany Martins Tavoni & Raul Cavalcante Maranhão

  4. Alta Medicina Diagnóstica, São Paulo, Brazil

    Manoel Orlando Gonçalves

  5. Department of Obstetrics and Gynecology, Medical School Hospital, University of Sao Paulo, São Paulo, Brazil

    Edmund Chada Baracat & Sergio Podgaec

Authors
  1. Roberta Avila-Tavares
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luciano Gibran
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luiz Gustavo Oliveira Brito
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thauany Martins Tavoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Manoel Orlando Gonçalves
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Edmund Chada Baracat
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Raul Cavalcante Maranhão
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sergio Podgaec
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberta Avila-Tavares.

Ethics declarations

Conflict of interest

R.A-T. has nothing to disclose. L.G. has nothing to disclose.L.G.O.B. has nothing to disclose. T.M.T. has nothing to disclose. M.O.G. has nothing to disclose. E.C.B. has nothing to disclose.R.C.M. has nothing to disclose. S.P. has nothing to disclose.

Data sharing statement

All data generated in the current study are available from the corresponding author upon request.

IRB ethical approval statement

The study protocol was approved by the Institutional Review Board of the Perola Byington Hospital (#1.937.704) and by the Ethical Committee of the Hospital of the School of Medicine of the University of Sao Paulo (#3.402.300).

Trial registration:

RBR-7jx2byj, URL: https://ensaiosclinicos.gov.br/rg/RBR-7jx2byj Date of registration: 01/11/22.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Avila-Tavares, R., Gibran, L., Brito, L.G.O. et al. Pilot study of treatment of patients with deep infiltrative endometriosis with methotrexate carried in lipid nanoparticles. Arch Gynecol Obstet 309, 659–667 (2024). https://doi.org/10.1007/s00404-023-07246-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-023-07246-8

Keywords

Search

Navigation